DIMERISIERTES PEPTID

European patent · EP1584627 · Deleted

Register entry

Publication number
EP1584627
Application number
EP04702444
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jan 15, 2004
Published
Oct 12, 2005
Granted
Oct 7, 2009
Deleted
Jan 15, 2024
Reason
Maximum term reached
IPC classes
C07K 7/06 (2006.01)
C07K 7/08 (2006.01)
C07K 14/82 (2006.01)
A61K 39/00 (2006.01)
A61P 35/00 (2006.01)
A61P 37/04 (2006.01)
C07K 14/705 (2006.01)
Priority
JP 2003007122 15.01.2003
PCT application
PCT/JP2004/000254 15.01.2004
PCT publication
WO2004/063217 29.07.2004
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 15, 2024

    Maximum term reached

    Published in Swissreg on 15.01.2024

  2. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  3. Jun 8, 2022

    Address changed

    Owner
    International Institute of Cancer Immunology, Inc., 13-9, Enoki-cho, Suita-shi, Osaka-fu, Japan, Sumitomo Dainippon Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-8524, Japan → International Institute of Cancer Immunology, Inc., 13-9, Enoki-cho, Suita-shi, Osaka-fu, Japan, Sumitomo Pharma Co., Ltd., 6-8, Doshomachi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-0045, Japan

    Published in Swissreg on 08.06.2022

  4. May 19, 2016

    Transferred

    Owner
    International Institute of Cancer Immunology, Inc., 13-9, Enoki-cho, Suita-shi, Osaka-fu, Japan, CHUGAI SEIYAKU KABUSHIKI KAISHA, 5-1, Ukima 5-chome,, Kita-ku, Tokyo, 115-8543, Japan, Sumitomo Dainippon Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-8524, Japan → International Institute of Cancer Immunology, Inc., 13-9, Enoki-cho, Suita-shi, Osaka-fu, Japan, Sumitomo Dainippon Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-8524, Japan

    Published in Swissreg on 19.05.2016

  5. Sep 23, 2014

    Address changed

    Owner
    International Institute of Cancer Immunology, Inc., 13-9, Enoki-cho, Suita-shi, Osaka-fu, Japan, CHUGAI SEIYAKU KABUSHIKI KAISHA, 5-1, Ukima 5-chome,, Kita-ku, Tokyo, 115-8543, Japan, Dainippon Sumitomo Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka-fu, Japan → International Institute of Cancer Immunology, Inc., 13-9, Enoki-cho, Suita-shi, Osaka-fu, Japan, CHUGAI SEIYAKU KABUSHIKI KAISHA, 5-1, Ukima 5-chome,, Kita-ku, Tokyo, 115-8543, Japan, Sumitomo Dainippon Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-8524, Japan

    Published in Swissreg on 23.09.2014

  6. Jul 16, 2014

    Address changed

    Representative
    BOHEST AG, Postfach 160, 4003 Basel → BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 16.07.2014

  7. Oct 16, 2009

    Agent entered

    Representative
    BOHEST AG, Postfach 160, 4003 Basel

    Published in Swissreg on 16.10.2009

  8. Oct 7, 2009

    Granted

    Published in Swissreg on 07.10.2009

Parties

Holder

International Institute of Cancer Immunology, Inc.

13-9, Enoki-cho, Suita-shi, Osaka-fu, JP

Sumitomo Pharma Co., Ltd.

6-8, Doshomachi 2-chome Chuo-ku Osaka-shi, Osaka 541-0045, JP

Agent

BOHEST AG

Holbeinstrasse 36-38, 4051 Basel

Inventor

TAKASU, Hideo

Nishinomiya-shi, Hyogo 6620084, JP

SAMIZO, Fumio

Suita-shi, Osaka 5650854, JP

SUGIYAMA, Haruo

Minoo-shi, Osaka 5620036, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.